ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

0.4277
-0.0473
(-9.96%)
Cerrado 15 Enero 3:00PM
0.55
0.1223
(28.59%)
Fuera de horario: 6:59PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.55
Postura de Compra
0.53
Postura de Venta
0.55
Volume Operado de la Acción
241,310
0.4277 Rango del Día 0.4988
0.4277 Rango de 52 semanas 3.4899
Capitalización de Mercado [m]
Precio Anterior
0.475
Precio de Apertura
0.4988
Última hora de negociación
Volumen financiero
US$ 108,186
Precio Promedio Ponderado
0.448326
Volumen promedio (3 m)
42,883
Acciones en circulación
6,958,371
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.06
Beneficio por acción (BPA)
-7.03
turnover
-
Beneficio neto
-48.93M

Acerca de Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.48. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.4277 to US$ 3.4899.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$3.31 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.06.

HEPA Últimas noticias

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0101-1.803249419750.56010.59990.4277325650.50239919CS
4-0.01-1.785714285710.560.73450.4277742380.56586901CS
12-0.121-18.03278688520.6710.740.4277428830.6034083CS
26-0.49-47.11538461541.041.120.42771046400.75074506CS
52-2.21-80.07246376812.763.48990.4277801461.16362562CS
156-22.25-97.587719298222.826.60.427721086813.20900082CS
260-103.85-99.4731800766104.41500.427788884140.55159384CS

HEPA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Hepion Pharmaceuticals?
El precio actual de las acciones de Hepion Pharmaceuticals es US$ 0.55
¿Cuántas acciones de Hepion Pharmaceuticals están en circulación?
Hepion Pharmaceuticals tiene 6,958,371 acciones en circulación
¿Cuál es la capitalización de mercado de Hepion Pharmaceuticals?
La capitalización de mercado de Hepion Pharmaceuticals es USD 3.31M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Hepion Pharmaceuticals?
Hepion Pharmaceuticals ha negociado en un rango de US$ 0.4277 a US$ 3.4899 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Hepion Pharmaceuticals?
El ratio precio/beneficio de Hepion Pharmaceuticals es -0.06
¿Cuál es la moneda de reporte de Hepion Pharmaceuticals?
Hepion Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Hepion Pharmaceuticals?
El último beneficio anual de Hepion Pharmaceuticals es USD -48.93M
¿Cuál es la dirección registrada de Hepion Pharmaceuticals?
La dirección registrada de Hepion Pharmaceuticals es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Hepion Pharmaceuticals?
La dirección del sitio web de Hepion Pharmaceuticals es www.hepion.com
¿En qué sector industrial opera Hepion Pharmaceuticals?
Hepion Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
HUBCWHub Cyber Security Ltd
US$ 0.0399
(97.52%)
238.98k
SGBXSafe and Green Holdings Corporation
US$ 0.9399
(74.06%)
202.27M
BKYIBIO key International Inc
US$ 2.28
(66.42%)
199.2M
KITTNauticus Robotics Inc
US$ 3.10
(56.57%)
61.55M
QUBTQuantum Computing Inc
US$ 11.55
(55.45%)
113.75M
PTLEPTL Ltd
US$ 4.28
(-70.52%)
7.88M
WNWMeiwu Technology Company Ltd
US$ 0.3882
(-59.14%)
29.59M
ACONAclarion Inc
US$ 0.0428
(-55.32%)
168.62M
SVMHSRIVARU Holding Ltd
US$ 0.9195
(-38.70%)
5.53M
RIMEAlgorhythm Holdings Inc
US$ 0.0498
(-36.32%)
106.27M
RGTIRigetti Computing Inc
US$ 10.915
(21.96%)
390.24M
SGBXSafe and Green Holdings Corporation
US$ 0.9399
(74.06%)
202.27M
BKYIBIO key International Inc
US$ 2.28
(66.42%)
199.2M
NVDANVIDIA Corporation
US$ 136.24
(3.40%)
185.84M
ACONAclarion Inc
US$ 0.0428
(-55.32%)
168.62M

HEPA Discussion

Ver más
tw0122 tw0122 3 meses hace
HEPA give it a holler .85 + 40%
👍️0
blue finch blue finch 5 meses hace
i remember you from vitra
we all
made money
👍️0
Ruffieruff Ruffieruff 5 meses hace
Yup. Seem to find em all.
👍️0
blue finch blue finch 5 meses hace
ugh
Another scam
WTF
👍️0
Monksdream Monksdream 5 meses hace
HEPA new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
HEPA new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
HEPA new 52 week low
👍️0
Ruffieruff Ruffieruff 6 meses hace
Scam. All shareholders continues to get screwed.
👍️0
Monksdream Monksdream 6 meses hace
Whoops, I did it, again
👍️0
Awl416 Awl416 6 meses hace
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
👍️0
Monksdream Monksdream 6 meses hace
HEPA under $2
👍️0
Monksdream Monksdream 6 meses hace
HEPA under $2
👍️0
Awl416 Awl416 9 meses hace
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
👍️0
Monksdream Monksdream 11 meses hace
HEPA new 52 week low
👍️0
Monksdream Monksdream 12 meses hace
HEPA new 52 week low
👍️0
Ruffieruff Ruffieruff 2 años hace
POS
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 años hace
Any thoughts on whether they could see accelerated approval now? results were good and there are no good alternatives.
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 años hace
What if it is a lush partnership instead?
👍️0
shurtha2000 shurtha2000 2 años hace
Thanks
👍️0
Disquisition Disquisition 2 años hace
Absolutely correct, sir
👍️0
make it happen make it happen 2 años hace
Don't forget it's a delinquent stock has failed to meet requirements ie r/s to raise more funds rinse and repeat for at least another 3 years and if one bad thing happens expect a 90% haircut immediately imho
👍️0
Disquisition Disquisition 2 años hace
people DUMPING knowing the OFFERING is imminent…
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 años hace
GOOD CALL: after R/S This could be a moon shot on good top line results
👍️0
da_stock_analyst da_stock_analyst 2 años hace
#HEPA ?? 117% move today! Looking strong and ready for tomorrow! $HEPA
👍️0
make it happen make it happen 2 años hace
R/S, huge double digit negative returns, burning capital, zero Profitability

Management Effectiveness
Return on Assets -42.63%
Return on Equity  -78.41%

Cash Flow Statement
Operating Cash Flow -33.05M
Levered Free Cash Flow -16.86M

Profitability
Profit Margin. 0.00%
Operating Margin 0.00%

Yahoo

It is losing/spending more than its market cap. Imho will fade back to singles and dilute. It can't keep operations running without selling shares to share holders.
👍️0
Disquisition Disquisition 2 años hace
Yes (for up to $350 million)

and Yes (check the latest 10Q - very little cash left on hand)
👍️0
TheFinalCD TheFinalCD 2 años hace
DO THEY HAVE A SHELF OFFERING TO DRAW FROM?

ARE THEY CURRENTLY IN NEED OF CASH FROM AN OFFERING?

Message in reply to:
Offering tonight or tomorrow. Called it
👍️0
TheFinalCD TheFinalCD 2 años hace
GOOD CALL
after R/S This could be a moon shot on good top line results
👍️ 1
Pt3 Pt3 2 años hace
Call wrong baby ....Biden say No more offering.... inflation is extremely now
👍️0
Disquisition Disquisition 2 años hace
Offering tonight or tomorrow. Called it
👍️0
Triple nickle Triple nickle 2 años hace
Might jus do it
👍️0
Triple nickle Triple nickle 2 años hace
Gotta bust thru 16.40 and hold it
👍️0
makinezmoney makinezmoney 2 años hace
$HEPA : Meeting those PRIMARY ENDPOINTS


Another MDGL kinda booster about to happen here.... now $15



GO $HEPA
👍️0
Ruffieruff Ruffieruff 2 años hace
This is not even .80c PS. Whose selling?
👍️0
shurtha2000 shurtha2000 2 años hace
$15.73 building a new base
👍️0
Disquisition Disquisition 2 años hace
DUMPED all my 7zzzz at 16
👍️0
shurtha2000 shurtha2000 2 años hace
Achieves primary and secondary endpoints its all good

https://finance.yahoo.com/news/hepion-pharmaceuticals-phase-2-altitude-110000500.html
👍️0
shurtha2000 shurtha2000 2 años hace
Will Pre-market trading be suspended ?
👍️0
tw0122 tw0122 2 años hace
830 am
Monday’s conference call update
👍️0
shurtha2000 shurtha2000 2 años hace
after R/S This could be a moon shot on good top line results
👍️ 1
Ruffieruff Ruffieruff 2 años hace
But it all. Taking knife. We are scammed.
👍️ 1
makinezmoney makinezmoney 2 años hace
$HEPA: So the RS happened........ now $9

But on a downdip........... will have to get some more if this dips sub $9


GO $HEPA
👍️0
Ruffieruff Ruffieruff 2 años hace
Your shares look like crap like the rest of us!! Pumper
👍️ 1
Ruffieruff Ruffieruff 2 años hace
Scumbags!!
👍️ 1
blue finch blue finch 2 años hace
I'd consider getting back at .36
👍️0
blue finch blue finch 2 años hace
Why
👍️0
Ruffieruff Ruffieruff 2 años hace
Good thing you dumped this dog.
👍️0
Ruffieruff Ruffieruff 2 años hace
Pumper come back. Where have you been? We need another boost and lecture. Pumper rah rah rah.
👍️0
Ruffieruff Ruffieruff 2 años hace
This is dogchit!!
👍️0
Ruffieruff Ruffieruff 2 años hace
Just added some SAB members. Lets see if we finally get some real info.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock